Houston, TX, United States of America

Rodabe Amaria

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rodabe Amaria: Innovator in Cancer Treatment

Introduction

Rodabe Amaria is a prominent inventor based in Houston, Texas, known for his significant contributions to cancer treatment. He has developed innovative methods that combine topoisomerase-I inhibitors with immunotherapy, aiming to enhance the effectiveness of cancer therapies. His work is crucial in the ongoing battle against cancer, providing new avenues for treatment.

Latest Patents

Rodabe Amaria holds a patent for a groundbreaking invention titled "Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer." This patent focuses on compositions and methods for treating cancer, specifically utilizing a Topoisomerase I inhibitor alongside an α-PD-L1 antibody. This innovative approach has the potential to improve patient outcomes in cancer therapy.

Career Highlights

Amaria is affiliated with the University of Texas System, where he conducts research and develops new treatment methodologies. His work is characterized by a commitment to advancing medical science and improving therapeutic options for cancer patients. With a patent portfolio that includes 1 patent, he continues to make strides in the field of oncology.

Collaborations

Throughout his career, Rodabe Amaria has collaborated with esteemed colleagues such as Patrick Hwu and Jodi A McKenzie. These partnerships have fostered a collaborative environment that enhances research and innovation in cancer treatment.

Conclusion

Rodabe Amaria's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving patient care. His work at the University of Texas System and collaborations with other experts highlight the importance of teamwork in advancing medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…